InnovHeart is based in Milano, Italy. It has raised $79M in total funding. Latest round: Series C.
InnovHeart funding overview
InnovHeart is based in Milano, Italy. InnovHeart has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2022. The round record for InnovHeart runs through 2022; nothing later has been disclosed. Investors on record include Indaco Venture Partners, Cassa Depositi e Prestiti Group, China Grand Pharmaceutical and Healthcare. 3 distinct backers are named across the disclosed rounds.
InnovHeart at a glance
Total raised
$79M
Latest round
Series C
Latest round date
January 2022
Headquarters
Milano, Italy
Notable investors
Indaco Venture Partners, Cassa Depositi e Prestiti Group, China Grand Pharmaceutical and Healthcare
Frequently asked about InnovHeart funding
How much has InnovHeart raised?
InnovHeart has raised $79M in total disclosed funding across the rounds on record.
Who has invested in InnovHeart?
Indaco Venture Partners, Cassa Depositi e Prestiti Group, China Grand Pharmaceutical and Healthcare are named among the investors backing InnovHeart.
What was the latest InnovHeart funding round?
The most recent disclosed round is a Series C, announced in January 2022.
Where is InnovHeart based?
InnovHeart is based in Milano, Italy.
When did InnovHeart last raise?
The last disclosed InnovHeart round closed in January 2022 at Series C.
Totals shown for InnovHeart aggregate every disclosed round on file. To see how that compares, browse the companies in Milano and the investors behind them below.
